A new clopidogrel (Plavix) point-of-care assay: Rapid determination of antiplatelet activity in trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 1, 2011, Pages 65-70

  Bansal, Vishal ^a   Fortlage, Dale ^a   Lee, Jeanne ^a   Doucet, Jay ^a   Potenza, Bruce ^a   Coimbra, Raul ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Anticoagulation; Clopidogrel; Platelet inhibition; Trauma

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DRUG ACTIVITY; FALLING; FEMALE; HUMAN; INJURY; INJURY SCALE; MALE; PRIORITY JOURNAL;

AGED; FEMALE; HEMORRHAGE; HUMANS; INJURY SEVERITY SCORE; MALE; PLATELET AGGREGATION INHIBITORS; POINT-OF-CARE SYSTEMS; RETROSPECTIVE STUDIES; TICLOPIDINE; WOUNDS AND INJURIES;

EID: 78751604708     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318204fdae     Document Type: Article

References (25)

1. Dellinger AM, Stevens JA. The injury problem among older adults: mortality, morbidity and costs. J Saf Res. 2006;37:519-522.
2. Lev EI, Patel RT, Maresh KJ, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role ofdual drug resistance. J Am Coll Cardiol. 2006;47:27-33.
3. Mina AA, Knipfer JF, Park DY, Bair HA, Howells GA, Bendick PJ. Intracranial complications of preinjury anticoagulation in trauma patients with head injury. J Trauma. 2002;53:668-672.
4. Lavoie A, Ratte S, Clas D, et al. Preinjury warfarin use among elderly patients with closed head injuries in a trauma center. J Trauma. 2004; 56:802-807.
5. Franko J, Kish KJ, O'Connell BG, Subramanian S, Yuschak JV. Ad-vanced age and preinjury warfarin anticoagulation increase the risk of mortality after head trauma. J Trauma. 2006;61:107-110.
6. McMillian WD, Rogers FB. Management of prehospital antiplatelet and anticoagulant therapy in traumatic head injury: a review. J Trauma. 2009;66:942-950.
7. Bouman HJ, Parlak E, van Werkum JW, et al. Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacoki-netic analysis on the active metabolite of clopidogrel. J Thromb Hae-most. 2010;8:482-488.
8. Oestreich JH, Holt J, Dunn SP, et al. Considerable variability in platelet activity among patients with coronary artery disease in response to an increased maintenance dose ofclopidogrel. Coron Artery Dis. 2009;20: 207-213.
9. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009;104:227-233.
10. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol. 2005;45:246-251.
11. Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM. ACCF/AHA clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the American Heart Association endorsed by the Society for Cardiovascular Angiog-raphy and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2010;56:321-341.
12. Cuisset T, Frere C, Quilici J, et al. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coro-nary syndrome. Thromb Res. 2007;120:893-899.
13. Jakubowski JA, Payne CD, Li YG, et al. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel admin-istration. Thromb Haemost. 2008;99:409-415.
14. Malinin A, Pokov A, Spergling M, et al. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study. Thromb Res. 2007;119:277-284.
15. Cuisset T, Frere C, Poyet R, et al. Clopidogrel response: head-to-head comparison of different platelet assays to identify clopidogrel non responder patients after coronary stenting. Arch Cardiovasc Dis. 2010; 103:39-45.
16. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation. 2003;107:2908-2913.
17. Jones K, Sharp C, Mangram AJ, Dunn EL. The effects of preinjury clopidogrel use on older trauma patients with head injuries. Am J Surg. 2006;192:743-745.
18. Wong DK, Lurie F, Wong LL. The effects of clopidogrel on elderly traumatic brain injured patients. J Trauma. 2008;65:1303-1308.
19. Fortuna GR, Mueller EW, J Ames LE, Shutter LA, Butler KL. The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on out-comes in elderly patients with hemorrhagic brain injury. Surgery. 2008; 144:598-603; discussion 603-605.
20. Ohm C, Mina A, Howells G, Bair H, Bendick P. Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. J Trauma. 2005;58:518-522.
21. Ott MM, Eriksson E, Vanderkolk W, Christianson D, Davis A, Scholten D. Antiplatelet and anticoagulation therapies do not in-crease mortality in the absence of traumatic brain injury. J Trauma. 2010;68:560-563.
22. Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. J Cardiothorac Vasc Anesth. 2007; 21:851-854.
23. Downey DM, Monson B, Butler KL, et al. Does platelet administration affect mortality in elderly head-injured patients taking antiplatelet med-ications? Am Surg. 2009;75:1100-1103.
24. Van Werkum JM, Van Der Stelt CA, Seesing TH, et al. A head-to-head comparison between the VerifyNow P2Y12 assay and light transmit-tance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary inter-vention. J Thromb Haemost. 2006;4:2516-8.
25. Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251:604-614.